Breaking News
Get 40% Off 0
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list
Close

Vaxart Inc (VXRT)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Vaxart's earnings

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
0.7556 -0.0867    -10.29%
16:00:00 - Closed. Currency in USD ( Disclaimer )
After Hours
0.7660
+0.0104
+1.3764%
18:57:02 - Real-time Data
Type:  Equity
Market:  United States
  • Volume: 1,888,439
  • Bid/Ask: 0.0000 / 0.0000
  • Day's Range: 0.7503 - 0.8550
Vaxart 0.7556 -0.0867 -10.29%

Vaxart Inc Company Profile

 
Get an in-depth profile of Vaxart Inc, including a general overview of the company's business and key management, as well as employee data and location and contact information.
IndustryBiotechnology & Medical Research
SectorHealthcare
Employees

109

Equity Type

ORD

Vaxart, Inc., a clinical-stage biotechnology company, discovers and develops oral recombinant protein vaccines based on its proprietary oral vaccine platform. The company’s product pipeline includes norovirus vaccine, a bivalent oral tablet vaccine in Phase 2 clinical trial for the GI.1 and GII.4 norovirus strains; coronavirus vaccine, which is in Phase 2 clinical trial, for the treatment of SARS-CoV-2 infection; seasonal influenza vaccine, which is in Phase 2 clinical trial, to treat H1 influenza infection; and human papillomavirus therapeutic vaccine, which is in preclinical stage, that targets HPV-16 and HPV-18 for cervical cancers and precancerous cervical lesions. It has a license agreement with Altesa Biosciences, Inc. to develop and commercialize Vapendavir, a capsid-binding broad-spectrum antiviral. Vaxart, Inc. is headquartered in South San Francisco, California.

Contact Information

Address 170 Harbor Way Suite 300
South San Francisco, 94080
United States
Phone 650 550 3500
Fax 650 871 8580

Top Executives

Name Age Since Title
Michael J. Finney 65 2018 Chairman of the Board
David E. Wheadon 65 2021 Independent Lead Director
James Robinson 63 - Member of Manufacturing & Quality Advisory Board
Steven Lo 57 2024 President, CEO & Director
Stefan Gravenstein - 2021 Member of Scientific & Clinical Advisory Board
Gregory C. Gray - 2021 Member of Scientific & Clinical Advisory Board
John F. Carpenter - 2021 Member of Manufacturing & Quality?Advisory?Board
Robert B. Belshe - 2021 Member of Scientific & Clinical Advisory Board
Benjamin J. Del Tito 68 2021 Member of Manufacturing & Quality?Advisory?Board
George R. Siber 79 2021 Member of Scientific & Clinical Advisory Board
Harry B. Greenberg - 2021 Member of Scientific & Clinical Advisory Board
William Mark Watson 74 2022 Director
Elaine J. Heron 76 2022 Director
Ralph Baric - 2021 Member of Scientific & Clinical Advisory Board
Marion Pepper - 2021 Member of Scientific & Clinical Advisory Board
Vijay Jethwa - 2021 Member of Manufacturing & Quality?Advisory?Board
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

VXRT Comments

Write your thoughts about Vaxart Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Jeff Bailey
JeffB Apr 05, 2024 4:03PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
VXRT $1.08 -4.42% at Friday Close!
Jeff Bailey
JeffB Mar 15, 2024 11:20PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
VXRT $1.08 -1.82% at Friday close!
Jeff Bailey
JeffB Mar 08, 2024 5:25PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
VXRT $1.19 +7.21% at Friday close!
Jeff Bailey
JeffB Mar 07, 2024 4:03PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
VXRT $1.11 -7.50% at Close!
Antonio Guerreiro
Antonio Guerreiro Mar 04, 2024 12:13PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
where will this go?
Jeff Bailey
JeffB Mar 04, 2024 12:13PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Don't go around promoting stocks in various chats, then ask that question. When you recommend the purchase of shares, post a target and a stop loss.
Jeff Bailey
JeffB Feb 29, 2024 5:04PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
VXRT $1.22 -5.79% at the 02/29/24 close!
Jeff Bailey
JeffB Feb 23, 2024 4:14PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
VXRT $1.27 -9.29% at close! Volume heavy at 2.3M shares changing hands!
Jeff Bailey
JeffB Feb 22, 2024 4:27PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
VXRT $1.40 -0.71% at close!
Jeff Bailey
JeffB Feb 22, 2024 4:27PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
180 day simple moving average at $0.78.
Antonio Guerreiro
Antonio Guerreiro Feb 21, 2024 12:47PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Up we go....
Jeff Bailey
JeffB Feb 21, 2024 12:47PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
$1.41 at the close!
Antonio Guerreiro
Antonio Guerreiro Feb 21, 2024 12:47PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
looking for 2 up soon
Charles Resheske
Charles Resheske Jun 06, 2022 11:40PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
all talk no action
Antonio Guerreiro
Antonio Guerreiro Jun 06, 2022 11:40PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
buy!! just buy!
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email